Conversely, human CRC patient‐derived tumoroids (PDTs) with active TGF‐β pathway status mostly displayed tumor‐suppressive effects, indicated by upregulation of CDK inhibitors, and in PDTs, which showed undisturbed proliferation, no signs of EMT were evident [4]. This evidence concerns the gene TGFB1 and neoplasm.